Enasidenib mesylate (1650550-25-6)pharmasino2025-07-03T06:36:17+00:00 Product InformationRelated ProductsAdditional InformationSupport & HelpAPIAnti-TumorCarfilzomibEnasidenib mesylate (1650550-25-6)Product: Enasidenib Mesylate Description: CAS: 1650550-25-6; Enasidenib manufacturer; Enasidenib API; Anti-tumor Category: Anti-Tumor In-stock: In Stock Payment Method: T/T, L/C Shipping Method: AIR, Express Add To Inquiry ListProduct Information CAS No. 1650550-25-6 Specification CP, EP, As Required M.F. C20H21F6N7O4S M.W. 569.48 Assay 98% Shelf Life 2 Years Package 25kg/drum Highlight FARMASINO Enasidenib Mesylate FARMASINO Enasidenib manufacturer FARMASINO Enasidenib API Related Products Leucovorin calcium (1492-18-8) Gallery Leucovorin calcium (1492-18-8) Levofolinate Calcium (80433-71-2) Gallery Levofolinate Calcium (80433-71-2) (αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate (179324-87-9) Gallery (αR)-(1S,2S,3R,5S)-Pinanediol-1-amino-3-methylbutane-1-boronate Trifluoroacetate (179324-87-9) Ixazomib Citrate (1201902-80-8) Gallery Ixazomib Citrate (1201902-80-8) 2-(2,5-dichlorobenzamido)acetic acid (667403-46-5) Gallery 2-(2,5-dichlorobenzamido)acetic acid (667403-46-5) 1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one (18048-64-1) Gallery 1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one (18048-64-1) Eltrombopag Olamine (496775-62-3) Gallery Eltrombopag Olamine (496775-62-3) 3-bromo-2-methoxyaniline (116557-46-1) Gallery 3-bromo-2-methoxyaniline (116557-46-1) Additional InformationApplication Enasidenib is a first-in-class oral selective inhibitor of mutant IDH2 enzymes (isocitrate dehydrogenase 2), for the treatment of adults with relapsed or refractory IDH2-mutated acute myeloid leukemia. Storage temp:Store at -20°C Solubility:DMSO : ≥ 100 mg/mL (175.60 mM) Form:Solid Color:White to off-white Support & HelpFirst name *Last name *Email *Product InterestsAPIPharmaceuticalsMedical DevicesSupplementsVeterinaryBudgetYour messageSend enquirySend enquiryThank you for your message. It has been sent.×There was an error trying to send your message. Please try again later.× *For more information about our products email us at: market@pharmasino.com Share This Story, Choose Your Platform! FacebookXLinkedInPinterest
